BioSpace News Archive

Global biotherapeutics leader CSL Behring today announced that the European Academy of Neurology (EAN) and Peripheral Nerve Society (PNS) Task Force has released an update to its guideline on diagnosis and treatment of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).

Alpha Cognition Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating neurodegenerative disorders, announces the grant of 3,500,000 stock options to certain officers and employees of the Company pursuant to the Company’s stock option plan.

The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Vacuum therapy devices are medical suction devices primarily used for different vacuum therapy and impotence disorders, such as negative pressure wound therapy (NPWT).

The IVF services market in emerging markets has witnessed significant growth, as the prices of IVF services are lower when compared to the developed countries.

Rise in importance of vital signs monitoring devices in home care settings and improved reimbursement scenario in developed countries drive growth of the global vital signs monitoring devices market.

Biocom California, the association representing the California life science industry, today announced a call for entries for the sixth annual Life Science Catalyst Awards.

Notable, the leading intelligent automation company for healthcare, announced today it will unveil the healthcare industry’s first digital ecosystem for automated workflows at the 2021 HIMSS Global Health Conference & Exhibition (HIMSS) taking place in Las Vegas, August 9-13.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, announced today the availability of a presentation on its corporate website to provide an overview of Sorrento’s proprietary mRNA vaccine development program for COVID-19.

Medline today announced new customer contracts, representing more than 50 hospitals across the U.S., for PrefConnect® , a digital preference card review system to help ensure accurate and complete operating room supply pick lists.